MAIA Biotech executives receive salary hikes and new terms
In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has ...
The Scientist1 年
Survey: Biotech Executives' Salary Hikes Indicate Industry's Health
The average annual base salary paid to executives at United States biotechnology companies--both privately and publicly owned--rose between 4.7 percent and 7.4 percent between 1991 and 1992, according ...
Business Insider3 年
Here are the 20 fastest growing biotech and pharma companies that pay people the most
Experts were already warning before the pandemic that biotech and pharma companies were growing faster than the number of scientists and researchers looking for jobs. Investors have poured record ...
MAIA Biotechnology Amends Employment Agreements with Executive Officers
MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) recently disclosed updates to the employment agreements of key executive officers in a Form 8-K filing dated February 1, 2025. The company entered into ...